Cooley has advised Vor Biopharma. Paul Hastings LLP has advised J.P. Morgan, Jefferies, Citigroup, and TD Cowen. Vor Biopharma Inc. has announced the pricing of an...
Vor Biopharma Announces $100 Million Public Offering of Common Stock
European Biotech Acquisition’s $200 Million Combination With Oculis
Davis Polk advised European Biotech Acquisition Corp. on the deal while Cooley and Vischer represented Oculis. European Biotech Acquisition Corp. (EBAC), a SPAC, signed its $200 million...